Results

Total Results: 1,229 records

Showing results for "adverse event".
Users also searched for: patient safety indicators

101. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/thromboembolism-update-executive-170622.pdf
     June 01, 2017 - • In THR, LMWH has lower VTE and adverse event risks than unfractionated heparin; LMWH and aspirin … One NRCS had high risk of bias for adverse event reporting and one was unclear. … Only about half of studies reported major bleeding, the adverse event of greatest concern for most … For VTE prophylaxis studies, there is a fairly standard list of VTE and adverse event outcomes that … Larger RCTs should evaluate differences in treatment and adverse event effects in relevant subgroups

102. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
     March 01, 2022 - event; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event … event; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event … event; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event … event; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event … event; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event

103. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_surveillance.pdf
     March 01, 2013 - See Key Question 3 on adverse events. … (Low) Mixed results for specific adverse events. … (Low) Mixed results for specific adverse events. … (Low) Mixed results for specific adverse events. … event and serious adverse events with adalimumab + MTX compared to abatacept + MTX.21 Tocilzumab

104. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_surveillance.pdf
     March 01, 2013 - See Key Question 3 on adverse events. … (Low) Mixed results for specific adverse events. … (Low) Mixed results for specific adverse events. … (Low) Mixed results for specific adverse events. … event and serious adverse events with adalimumab + MTX compared to abatacept + MTX.21 Tocilzumab

105. Osteoporosis-Bone-Fracture Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_executive.pdf
     March 01, 2012 - Studies that reported fracture only as an adverse event were excluded from effectiveness analysis; … were included in the adverse event analysis … included information on the relationship between the adverse event and the drug. … event analyses. … event.

106. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-adult-treatment_research-protocol.pdf
     December 20, 2011 - , rather than the event itself, determines an individual’s mood. … events: overall adverse events, withdrawals due to adverse events, and specific adverse events (including … KQ 6 looks as the adverse effects of these interventions. … effects), we will evaluate the trials included in KQs 1 through 4 that report adverse effects. … • Requires patient to associate each symptom with a specific traumatic event.

107. Appendix A - The Effect of Dietary Digestible Carbohydrate Intake on Risk of Cardiovascular Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/risk-cardiovascular-disease-appendix-a.pdf
     August 31, 2023 - arteriovenous or artery or arteries or arterial or vein or vein or veins or cerebrovascular) adj3 ("adverse … event*" or anomaly or anomalies or abnormalit* or defect or defects or disease* or complication* or … disturbance* or infection* or inflammation* or lesion* or malformation* or symptom* or syndrome* or event

108. Bladder-Cancer-Non-Muscle-Invasive Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_executive.pdf
     October 01, 2015 - events (SOE: low for local adverse events; insufficient for systemic adverse events). … BCG Versus MMC: • BCG was associated with increased risk of any local adverse event (2 trials; RR, … • BCG was associated with increased risk of any systemic adverse event (2 trials; RR, 2.01; 95% CI … risk of any local adverse event (2 trials; RR, 2.01; 95% CI, 1.59 to 2.54; I2 = 0%), granulomatous … MMC: Systemic adverse events Low BCG was associated with increased risk of any systemic adverse event

109. Appendix-E-Evidence-Tables-E1-E4 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Evidence-Tables-E1-E4_0.xlsx
     May 29, 2025 - Any Adverse Event Intervention B, N of Any Adverse Event (Numerator) Intervention B, N Analyzed for … Any Adverse Event (Denominator) Intervention B, % With Any Adverse Event Intervention A, N of Serious … A, % With Serious Adverse Event Intervention B, N of Serious Adverse Event (Numerator) Intervention … to Adverse Event (Denominator) Intervention A, % With Withdrawals Due to Adverse Event Intervention B … Adverse Event (Denominator) Intervention B, % With Withdrawals Due to Adverse Event Intervention A,

110. Executive summary_Comparative Effectiveness Review No. 250_Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2024 Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-executive-sum.pdf
     January 01, 2024 - that have potential analgesic effects as well as the potential for addiction, misuse, and serious adverse … There may be no increase in risk of serious adverse events (SOE: low) or withdrawal due to adverse events … • Other key adverse event outcomes (psychosis, cannabis use disorder, cognitive deficits) and outcomes … Other prioritized adverse events (cannabis use disorder [CUD], psychosis, cognitive deficits) and the … event; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event

111. Misuse of Prescription Stimulants in Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-prescription-protocol.pdf
     September 13, 2024 - cognitive impairment, and substance use disorders.10 This project will investigate the epidemiology and adverse … Outcome o Short-term  Overdoses, fatal and non-fatal  Health measures (cardiovascular, injuries, adverse … term")) OR (title: ("long term")) OR (title: ("longer term")) OR (title: (outcomes)) OR (title: ("adverse … event")) OR (title: ("adverse events")) OR (title: (consequence)) OR (title: (consequences)) OR (title … event")) OR (abstract: ("adverse events")) OR (abstract: (consequence)) OR (abstract: (consequences

112. Disposition of Comments Report for Evidence Report 215 Safety of Vaccines Used for Routine Immunization in the United States (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccine-safety_disposition-comments.pdf
     January 01, 2020 - TEP # 1 Introduction— Page 3 lines 11- 13 Change to “..the Vaccine Adverse Event Reporting System … It is also possible to have high or moderate strength of evidence for an extremely rare adverse event … Event Monitoring Substudy which comprised a subset of 6600+ subjects. … Similarly, event severity was poorly described. … An understanding of the severity of an adverse event is necessary for decision-makers to determine

113. Microsoft Word - Comp Eff 10.doc (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
     January 01, 2007 - • Safety (focusing on serious adverse event rates, overall adverse event rates, and withdrawals … Key Points • Cough was modestly more frequently observed as an adverse event in groups treated with … However, the nature of serious adverse event reporting was inconsistent, and rates of serious adverse … Depending on the definition used, adverse event rates ranged from 0 to 100 percent (median 32 percent … The one adverse event for which significant differential effects were apparent is cough.

114. Adverse Events Associated With COVID-19 Pharmaceutical Treatments | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/COVID-19-pharmaceutical-treatments/rapid-research

115. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 3 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
     May 01, 2022 - event; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event … event; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event … event; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event … event; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event … event; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event

116. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-update_executive.pdf
     December 01, 2011 - Differences in Harms (Adverse Events) (KQ 4a) We analyzed adverse-events data from 92 head-to-head efficacy … On average, 63 percent of patients in efficacy trials experienced at least one adverse event. … Other Severe Adverse Events The existing evidence on the comparative risk for rare but severe adverse … Comparative Harms and Adherence of Immediate- Versus Extended-Release Formulations (KQ 4b) Overall, adverse-event … Likewise, adverse-event rates were similar between paroxetine IR and paroxetine CR, as well as venlafaxine

117. Executive summary_Comparative Effectiveness Review No. 250_Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2025 Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2025-surv-rep-update-executive-sum.pdf
     January 01, 2025 - that have potential analgesic effects as well as the potential for addiction, misuse, and serious adverse … There may be no increase in risk of serious adverse events (SOE: low) or withdrawal due to adverse events … • Other key adverse event outcomes (psychosis, cannabis use disorder, cognitive deficits) and outcomes … Other prioritized adverse events (cannabis use disorder [CUD], psychosis, cognitive deficits) and the … event; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event

118. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-2007_executive.pdf
     January 01, 2007 - Many questions remain about the risks of these agents across a spectrum of adverse events from relatively … In general, adverse events did not differ significantly between biologic and synthetic DMARDs. … Studies were too small to assess reliably differences in rare but severe adverse events. … Studies, however, were too small to assess reliably differences in rare but severe adverse events. … The groups did not differ in serious adverse events.

119. Research White Paper: Outcome Measure Harmonization and Data Infrastructure for Patient-Centered Outcomes Research in Depression (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-outcome-measure-harmonization-depression.pdf
     November 01, 2020 - Events of Interest Adverse Events Depression treatment-related adverse events. … The adverse events measure also required a modification to capture adverse events related to procedures … Additional procedure codes were added to the Adverse Event value sets. … Potential challenges related to the availability of PHQ-9, adverse event, suicide, and mortality data … Adverse Events Data The intent of the adverse events measure is to capture all adverse events related

120. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-2007_executive.pdf
     January 01, 2007 - Gastrointestinal adverse events/problems. … Only one study reported an adverse event of thrombocytopenia and leucopenia, making comparisons between … , and consistently report all adverse events (not using aggregated events). … medications in withdrawals due to unspecified adverse events. events 4&5k. … event findings reported above. 6.